| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |